SCHEMBL22152151

SCHEMBL22152151

C[C@@H]1CN(c2cccc(NC(=O)c3ccc(NS(=O)(=O)CCF)cc3N3CCC4(CC3)CC4)n2)CCO1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KIF18A Q8NI77 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29608141 1.00 KIF18A (1.00) KIF18A
SCHEMBL22153017 0.94 KIF18A (1.00) KIF18A
SCHEMBL29608757 0.94 KIF18A (1.00) KIF18A
SCHEMBL24319140 0.94 KIF18A (1.00) KIF18A
SCHEMBL22152106 0.94 KIF18A (1.00) KIF18A
SCHEMBL29608727 0.94 KIF18A (1.00) KIF18A
SCHEMBL29608893 0.94 KIF18A (1.00) KIF18A
Hydrochloric Acid SCHEMBL30141776 0.93 KIF18A (0.99) KIF18A
Hydrochloric Acid SCHEMBL30141838 0.93 KIF18A (0.99) KIF18A
SCHEMBL22152136 0.93 KIF18A (1.00) KIF18A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3897855-B1 KIF18A INHIBITORS AMGEN INC (US) 2023-06-07 — — EP disclosed
US-20220073504-A1 KIF18A INHIBITORS AMGEN INC. (US) 2022-03-10 — — US disclosed
WO-2020132651-A1 KIF18A INHIBITORS AMGEN INC. (US) 2020-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073504-A1 KIF18A INHIBITORS KIF18A, KIF18B, KIF15 KIF18A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback